digraph structs {
rankdir=LR;
g0 [shape=record,label="http://purl.obolibrary.or\lg/obo/UO_0000187\l\lrdfs:Class\l",color=blue]
g1 [shape=record,label="http://dikb.org/object-dr\lug/61b6e142-a000-48c0-a0b\l5-eb9fac0bba1d\l\l\<http://purl.bioontology.\lorg/ontology/RXNORM/3407\>\l",color=blue]
g2 [shape=record,label="http://dikb.org/data-rati\lo/0bd05683-fd00-43ca-8238\l-5d77af592186\linformation about increas\le of pharmacokinetic area\l under the curve\lobo:DIDEO_00000050\l|label\lrdfs:label\lnefazodone-digoxin drug p\lackage auc Increase infor\lmation\l",color=blue]
g2 -> g53 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g2 -> g50 [label="has specified value\lobo:OBI_0001937\l"]
g3 [shape=record,label="http://dikb.org/assertion\l/1469a2a5-1993-4ed5-8cfb-\l340a275c9074\ldrug-drug interaction des\lcription\lobo:DIDEO_00000001\l|label\lrdfs:label\ldivalproex sodium-INVEGA \linteraction description\l",color=blue]
g3 -> g57 [label="has part\lobo:BFO_0000051\l"]
g3 -> g65 [label="\lobo:IAO_0000136\l"]
g3 -> g39 [label="has part\lobo:BFO_0000051\l"]
g3 -> g41 [label="\lobo:IAO_0000136\l"]
g4 [shape=record,label="http://purl.obolibrary.or\lg/obo/PATO_0000125\l\lrdfs:Class\l",color=blue]
g5 [shape=record,label="http://dikb.org/assertion\l/6266b22b-da1f-444a-b727-\lc1e6013d6138\ldrug-drug interaction des\lcription\lobo:DIDEO_00000001\l|label\lrdfs:label\lnefazodone-digoxin intera\lction description\l",color=blue]
g5 -> g10 [label="\lobo:IAO_0000136\l"]
g5 -> g25 [label="\lobo:IAO_0000136\l"]
g5 -> g30 [label="has part\lobo:BFO_0000051\l"]
g5 -> g2 [label="has part\lobo:BFO_0000051\l"]
g6 [shape=record,label="http://dikb.org/p-scatter\led-molecular-aggregate/4d\l29173c-6e18-4e9e-8ca8-c70\l4fec28b06\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g6 -> g19 [label="\lobo:RO_0002351\l"]
g6 -> g22 [label="\lobo:RO_0000053\l"]
g6 -> g68 [label="\lobo:RO_0000053\l"]
g7 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000050\l\lrdfs:Class\l",color=blue]
g8 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000576\l\lrdfs:Class\l",color=blue]
g9 [shape=record,label="http://dikb.org/object-mi\llligram/266d32f9-4fdd-480\la-bfd6-48b2d581af91\l\lobo:UO_0000022\l",color=blue]
g10 [shape=record,label="http://dikb.org/bearer-pr\lecipitant/c73c703f-2bec-4\l583-bc6d-2bfd504606d8\l",color=orange]
g10 -> g6 [label="has part\lobo:BFO_0000051\l"]
g10 -> g55 [label="\lobo:RO_0000053\l"]
g11 [shape=record,label="http://dikb.org/precipita\lnt-mass/fd8a9c0a-e760-49d\l4-926c-8cf200d0e371\l\lobo:PATO_0000125\l",color=blue]
g12 [shape=record,label="http://dikb.org/object-ac\ltive-ingredient/155b419a-\lfd08-4bf2-acab-8aee328426\l88\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g13 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000039\l\lrdf:Property\l",color=blue]
g14 [shape=record,label="http://dikb.org/method/e9\l34f7f0-d967-4381-b88e-5cf\ld5545c5dc\l\lobo:DIDEO_00000124\l|label\lrdfs:label\ldivalproex sodium-INVEGA \lDDI clinical trial\l",color=blue]
g15 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000312\l\lrdf:Property\l",color=blue]
g16 [shape=record,label="http://purl.obolibrary.or\lg/obo/BFO_0000051\l\lrdf:Property\l",color=blue]
g17 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/812d433b-\l06e2-4180-a91c-34691cd296\l0b\lpercent\lobo:UO_0000187\l",color=blue]
g18 [shape=record,label="http://dikb.org/precipita\lnt-value-measurement-datu\lm/9e66c8f3-4554-419d-80f2\l-eeab7d309b5c\l\lobo:IAO_0000109\l",color=blue]
g18 -> g31 [label="has specified value\lobo:OBI_0001937\l"]
g18 -> g11 [label="\lobo:IAO_0000221\l"]
g19 [shape=record,label="http://dikb.org/precipita\lnt-drug/a4cf25e2-c159-483\l8-a257-734b71b85ae7\l\l\<http://purl.bioontology.\lorg/ontology/RXNORM/31565\l\>\l",color=blue]
g20 [shape=record,label="http://dikb.org/p-scatter\led-molecular-aggregate/5e\lbf4c00-920f-4cd3-b232-a28\l69210d672\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g20 -> g58 [label="\lobo:RO_0000053\l"]
g20 -> g33 [label="\lobo:RO_0002351\l"]
g20 -> g18 [label="\lobo:RO_0000053\l"]
g21 [shape=record,label="http://dikb.org/object-dr\lug-role/a1ce9437-a925-4e8\le-9c8b-fec1cf618748\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g22 [shape=record,label="http://dikb.org/precipita\lnt-value-measurement-datu\lm/b2fb49a9-31e4-49f3-8723\l-b5928acedf92\l\lobo:IAO_0000109\l",color=blue]
g22 -> g48 [label="has specified value\lobo:OBI_0001937\l"]
g22 -> g56 [label="\lobo:IAO_0000221\l"]
g23 [shape=record,label="http://www.w3.org/1999/02\l/22-rdf-syntax-ns#type\l\lrdf:Property\l",color=blue]
g24 [shape=record,label="http://dikb.org/object-va\llue-specification/6ec0a98\l4-8a5a-47a6-bad3-6ef2b891\lbdb7\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l.2\l",color=blue]
g24 -> g9 [label="\lobo:IAO_0000039\l"]
g25 [shape=record,label="http://dikb.org/bearer-ob\lject/9967032f-7d91-4fc0-b\l7df-25cc9885c93d\l",color=orange]
g25 -> g21 [label="\lobo:RO_0000053\l"]
g25 -> g72 [label="has part\lobo:BFO_0000051\l"]
g26 [shape=record,label="http://dikb.org/object-ma\lss/ad700ae5-c77f-4774-966\l4-3e0de2015caa\l\lobo:PATO_0000125\l",color=blue]
g27 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000136\l\lrdf:Property\l",color=blue]
g28 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/5af8b923-\l73ae-42cf-bfe2-11e934e1db\l85\lpercent\lobo:UO_0000187\l",color=blue]
g29 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000001\l\lrdfs:Class\l",color=blue]
g30 [shape=record,label="http://dikb.org/data-rati\lo/8644a3a9-8124-4255-89a3\l-535580de7366\linformation about increas\le of pharmacokinetic area\l under the curve\lobo:DIDEO_00000050\l|label\lrdfs:label\lnefazodone-digoxin drug p\lackage cmax Increase info\lrmation\l",color=blue]
g30 -> g47 [label="has specified value\lobo:OBI_0001937\l"]
g30 -> g53 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g31 [shape=record,label="http://dikb.org/precipita\lnt-value-specification/11\l800d3c-8d98-4c16-9ef7-758\l350989a9b\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l1000\l",color=blue]
g31 -> g60 [label="\lobo:IAO_0000039\l"]
g32 [shape=record,label="http://dikb.org/object-mi\llligram/ddc0327f-a243-40e\l1-82e3-6fd334968951\l\lobo:UO_0000022\l",color=blue]
g33 [shape=record,label="http://dikb.org/precipita\lnt-drug/89b25ecb-02d0-41c\l8-acd0-9980a40a5cb4\l\l\<http://purl.bioontology.\lorg/ontology/RXNORM/D0146\l35\>\l",color=blue]
g34 [shape=record,label="http://dikb.org/object-dr\lug-role/335b5d77-4cf3-4df\lf-847a-8140bfd19c1c\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g35 [shape=record,label="http://dikb.org/object-ma\lss/7068e899-fce0-4421-bc6\l6-c781d4d63cf2\l\lobo:PATO_0000125\l",color=blue]
g36 [shape=record,label="http://dikb.org/object-dr\lug/852fdd39-1e50-4190-9d8\le-07f8957184bf\l\l\<http://purl.bioontology.\lorg/ontology/RXNORM/68643\l8\>\l",color=blue]
g37 [shape=record,label="http://dikb.org/precipita\lnt-drug-role/68680c24-d7e\lf-4e48-ac09-5a33a7d9448c\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g38 [shape=record,label="http://purl.obolibrary.or\lg/obo/UO_0000022\l\lrdfs:Class\l",color=blue]
g39 [shape=record,label="http://dikb.org/data-rati\lo/67973709-109b-4c13-a41e\l-2b2d17111100\linformation about increas\le of pharmacokinetic area\l under the curve\lobo:DIDEO_00000050\l|label\lrdfs:label\ldivalproex sodium-INVEGA \ldrug package cmax Increas\le information\l",color=blue]
g39 -> g14 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g39 -> g69 [label="has specified value\lobo:OBI_0001937\l"]
g40 [shape=record,label="http://dikb.org/object-va\llue-measurement-datum/a6c\ld0846-2e6d-4dea-ba39-3895\l4aa2f421\l\lobo:IAO_0000109\l",color=blue]
g40 -> g51 [label="has specified value\lobo:OBI_0001937\l"]
g40 -> g35 [label="\lobo:IAO_0000221\l"]
g41 [shape=record,label="http://dikb.org/bearer-ob\lject/951f6df0-2e07-4c92-b\ladb-9d75d3dd83f1\l",color=orange]
g41 -> g67 [label="has part\lobo:BFO_0000051\l"]
g41 -> g34 [label="\lobo:RO_0000053\l"]
g42 [shape=record,label="http://dikb.org/precipita\lnt-milligram/1c9eb0ef-eaa\lc-4d77-9104-b59ddaabef0e\l\lobo:UO_0000022\l",color=blue]
g43 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000124\l\lrdfs:Class\l",color=blue]
g44 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000221\l\lrdf:Property\l",color=blue]
g45 [shape=record,label="http://dikb.org/object-va\llue-measurement-datum/257\lab8ef-be23-4ddc-b213-1abf\le267ab66\l\lobo:IAO_0000109\l",color=blue]
g45 -> g24 [label="has specified value\lobo:OBI_0001937\l"]
g45 -> g26 [label="\lobo:IAO_0000221\l"]
g46 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/aab80707-\l9d7b-41ab-938a-7b17881394\lf8\lpercent\lobo:UO_0000187\l",color=blue]
g47 [shape=record,label="http://dikb.org/data-rati\lo-type/1ccb155e-a910-44d7\l-b35e-ab70e8a478df\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l29\l",color=blue]
g47 -> g28 [label="\lobo:OBI_0000051\l"]
g48 [shape=record,label="http://dikb.org/precipita\lnt-value-specification/da\lbf11e1-9f92-4d53-80f7-2ec\l3ce3f831f\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l200\l",color=blue]
g48 -> g42 [label="\lobo:IAO_0000039\l"]
g49 [shape=record,label="http://dikb.org/data-rati\lo-type/382cfac4-2c30-4da1\l-86a9-38cade235025\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l50\l",color=blue]
g49 -> g46 [label="\lobo:OBI_0000051\l"]
g50 [shape=record,label="http://dikb.org/data-rati\lo-type/8f219532-5405-403f\l-b45f-1f6ae53570cc\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l15\l",color=blue]
g50 -> g62 [label="\lobo:OBI_0000051\l"]
g51 [shape=record,label="http://dikb.org/object-va\llue-specification/c25fb41\l6-4562-4c72-8af4-6531ba87\l9368\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l12\l",color=blue]
g51 -> g32 [label="\lobo:IAO_0000039\l"]
g52 [shape=record,label="http://www.w3.org/2000/01\l/rdf-schema#label\l\lrdf:Property\l",color=blue]
g53 [shape=record,label="http://dikb.org/method/f7\l07038f-a71f-4130-9ac9-542\ldee6264d7\l\lobo:DIDEO_00000124\l|label\lrdfs:label\lnefazodone-digoxin DDI cl\linical trial\l",color=blue]
g54 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001937\l\lrdf:Property\l",color=blue]
g55 [shape=record,label="http://dikb.org/precipita\lnt-drug-role/a1c32f4b-06a\l2-4029-8f06-1e3fe8d63482\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g56 [shape=record,label="http://dikb.org/precipita\lnt-mass/f6628319-eb28-469\l7-9fac-92669a3941c0\l\lobo:PATO_0000125\l",color=blue]
g57 [shape=record,label="http://dikb.org/data-rati\lo/4a32b684-482b-409b-9aa0\l-ce4bd3fe13c4\linformation about increas\le of pharmacokinetic area\l under the curve\lobo:DIDEO_00000050\l|label\lrdfs:label\ldivalproex sodium-INVEGA \ldrug package auc Increase\l information\l",color=blue]
g57 -> g49 [label="has specified value\lobo:OBI_0001937\l"]
g57 -> g14 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g58 [shape=record,label="http://dikb.org/precipita\lnt-active-ingredient/b963\l6872-61ce-4b72-9235-52578\l242fe96\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g59 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001933\l\lrdfs:Class\l",color=blue]
g60 [shape=record,label="http://dikb.org/precipita\lnt-milligram/d53acebf-b7f\la-4717-9d3f-88a614628282\l\lobo:UO_0000022\l",color=blue]
g61 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0002351\l\lrdf:Property\l",color=blue]
g62 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/75360fdf-\l0595-49a2-85d3-3f1ba2a846\l79\lpercent\lobo:UO_0000187\l",color=blue]
g63 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000013\l\lrdfs:Class\l",color=blue]
g64 [shape=record,label="http://dikb.org/object-ac\ltive-ingredient/c8441bb4-\lb081-4f9c-9599-3615457ea8\la7\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g65 [shape=record,label="http://dikb.org/bearer-pr\lecipitant/9c02f0fd-e5a3-4\l7a5-b2d6-ee49e0c3a711\l",color=orange]
g65 -> g20 [label="has part\lobo:BFO_0000051\l"]
g65 -> g37 [label="\lobo:RO_0000053\l"]
g66 [shape=record,label="http://purl.obolibrary.or\lg/obo/DRON_00000028\l\lrdfs:Class\l",color=blue]
g67 [shape=record,label="http://dikb.org/o-scatter\led-molecular-aggregate/17\l09c056-ad27-4a89-8979-46c\lbc15146ac\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g67 -> g40 [label="\lobo:RO_0000053\l"]
g67 -> g36 [label="\lobo:RO_0002351\l"]
g67 -> g12 [label="\lobo:RO_0000053\l"]
g68 [shape=record,label="http://dikb.org/precipita\lnt-active-ingredient/3f07\lbdca-4434-4509-816f-fd379\lde9b80d\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g69 [shape=record,label="http://dikb.org/data-rati\lo-type/5b7b635b-0899-45c6\l-8f6c-4f4e7307a915\lvalue specification\lobo:OBI_0001933\l|label\lrdfs:label\l50 Percent \l",color=blue]
g69 -> g17 [label="\lobo:OBI_0000051\l"]
g70 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000051\l\lrdf:Property\l",color=blue]
g71 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000109\l\lrdfs:Class\l",color=blue]
g72 [shape=record,label="http://dikb.org/o-scatter\led-molecular-aggregate/88\l084207-f75f-4514-8e78-803\l2ab472446\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g72 -> g1 [label="\lobo:RO_0002351\l"]
g72 -> g45 [label="\lobo:RO_0000053\l"]
g72 -> g64 [label="\lobo:RO_0000053\l"]
g73 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0000053\l\lrdf:Property\l",color=blue]
}